With 9.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.16 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $20.6 whereas the lowest price it dropped to was $18.35. The 52-week range on OSCR shows that it touched its highest point at $19.04 and its lowest point at $4.72 during that stretch. It currently has a 1-year price target of $20.20. Beta for the stock currently stands at 1.66.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OSCR was up-trending over the past week, with a rise of 13.82%, but this was up by 33.85% over a month. Three-month performance surged to 45.47% while six-month performance rose 245.03%. The stock gained 175.73% in the past year, while it has gained 116.07% so far this year. A look at the trailing 12-month EPS for OSCR yields -1.21 with Next year EPS estimates of 0.40. For the next quarter, that number is 0.19. This implies an EPS growth rate of 92.16% for this year and 516.76% for next year.
Float and Shares Shorts:
At present, 193.87 million OSCR shares are outstanding with a float of 156.17 million shares on hand for trading. On 2024-04-15, short shares totaled 7.66 million, which was 323.00000000000006 higher than short shares on 1710460800. In addition to Mr. Mark Thomas Bertolini as the firm’s CEO & Director, Mr. Mario Tobias Schlosser serves as its Co-Founder, CTO, President of Technology & Director.
Institutional Ownership:
Through their ownership of 0.77518 of OSCR’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OSCR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
